Noninvasive evaluation of NAFLD (original) (raw)

• Angulo, P. Nonalcoholic fatty liver disease. N. Engl. J. Med. 346, 1221–1231 (2002).
  Article CAS PubMed Google Scholar
• Castera, L. & Pinzani, M. Non-invasive assessment of liver fibrosis: are we ready? Lancet 375, 1419–1420 (2010).
  Article PubMed Google Scholar
• Hamer, O. W. et al. Fatty liver: imaging patterns and pitfalls. Radiographics 26, 1637–1653 (2006).
  Article PubMed Google Scholar
• Schwenzer, N. F. et al. Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance. J. Hepatol. 51, 433–445 (2009).
  Article PubMed Google Scholar
• Webb, M. et al. Diagnostic value of a computerized hepatorenal index for sonographic quantification of liver steatosis. AJR Am. J. Roentgenol. 192, 909–914 (2009).
  Article PubMed Google Scholar
• Ratziu, V., Bellentani, S., Cortez-Pinto, H., Day, C. & Marchesini, G. A position statement on NAFLD/NASH based on the EASL 2009 special conference. J. Hepatol. 53, 372–384 (2010).
  PubMed Google Scholar
• Sasso, M. et al. Controlled attenuation parameter (CAP): a novel VCTE guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes. Ultrasound Med. Biol. 36, 1825–1835 (2010).
  Article PubMed Google Scholar
• de Ledinghen, V., Vergniol, J., Foucher, J., Merrouche W. & le Bail, B. Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography. Liver Int. 32, 911–918 (2012).
  Article PubMed Google Scholar
• Myers, R. P. et al. Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography. Liver Int. 32, 902–910 (2012).
  Article PubMed Google Scholar
• Sasso, M. et al. Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan((R.)): validation in chronic hepatitis C. J. Viral Hepat. 19, 244–253 (2012).
  Article CAS PubMed Google Scholar
• Friedrich-Rust, M. et al. Acoustic radiation force impulse-imaging and transient elastography for non-invasive assessment of liver fibrosis and steatosis in NAFLD. Eur. J. Radiol. 81, e325–e331 (2012).
  Article PubMed Google Scholar
• Masaki, K. et al. Utility of controlled attenuation parameter measurement for assessing liver steatosis in Japanese patients with chronic liver diseases. Hepatol. Res. http://dx.doi.org/10.1111/hepr.12094.
• Saadeh, S. et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 123, 745–750 (2002).
  Article PubMed Google Scholar
• Szczepaniak, L. S. et al. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am. J. Physiol. Endocrinol. Metab. 288, E462–E468 (2005).
  Article CAS PubMed Google Scholar
• Wong, V. W. et al. Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography. Gut 61, 409–415 (2012).
  Article PubMed Google Scholar
• Dixon, W. T. Simple proton spectroscopic imaging. Radiology 153, 189–194 (1984).
  Article CAS PubMed Google Scholar
• Guiu, B. et al. Quantification of liver fat content: comparison of triple-echo chemical shift gradient-echo imaging and in vivo proton MR spectroscopy. Radiology 250, 95–102 (2009).
  Article PubMed Google Scholar
• Lee, S. S. et al. Non-invasive assessment of hepatic steatosis: prospective comparison of the accuracy of imaging examinations. J. Hepatol. 52, 579–585 (2010).
  Article CAS PubMed Google Scholar
• van Werven, J. R. et al. Assessment of hepatic steatosis in patients undergoing liver resection: comparison of US, CT, T1-weighted dual-echo MR imaging, and point-resolved 1H MR spectroscopy. Radiology 256, 159–168 (2010).
  Article PubMed Google Scholar
• Poynard, T. et al. The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis. Comp. Hepatol. 4, 10 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Bedogni, G. et al. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 6, 33 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Bedogni, G., Kahn, H. S., Bellentani, S. & Tiribelli, C. A simple index of lipid overaccumulation is a good marker of liver steatosis. BMC Gastroenterol. 10, 98 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Kotronen, A. et al. Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors. Gastroenterology 137, 865–872 (2009).
  Article CAS PubMed Google Scholar
• Lee, J. H. et al. Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. Dig. Liver Dis. 42, 503–508 (2010).
  Article CAS PubMed Google Scholar
• Dam-Larsen, S. et al. Final results of a long-term, clinical follow-up in fatty liver patients. Scand. J. Gastroenterol. 44, 1236–1243 (2009).
  Article CAS PubMed Google Scholar
• Ekstedt, M. et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 44, 865–873 (2006).
  Article CAS PubMed Google Scholar
• Angulo, P. Long-term mortality in nonalcoholic fatty liver disease: is liver histology of any prognostic significance? Hepatology 51, 373–375 (2010).
  Article PubMed Google Scholar
• Younossi, Z. M. et al. Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver-related mortality. Hepatology 53, 1874–1882 (2011).
  Article PubMed Google Scholar
• Zardi, E. M. et al. Which clinical and sonographic parameters may be useful to discriminate NASH from steatosis? J. Clin. Gastroenterol. 45, 59–63 (2011).
  Article PubMed Google Scholar
• Suzuki, K. et al. Measurement of spleen volume is useful for distinguishing between simple steatosis and early-stage non-alcoholic steatohepatitis. Hepatol Res. 40, 693–700 (2010).
  Article CAS PubMed Google Scholar
• Chen, J. et al. Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography. Radiology 259, 749–756 (2011).
  Article PubMed PubMed Central Google Scholar
• Poynard, T. et al. Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease. BMC Gastroenterol. 6, 34 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Palekar, N. A., Naus, R., Larson, S. P., Ward, J. & Harrison, S. A. Clinical model for distinguishing nonalcoholic steatohepatitis from simple steatosis in patients with nonalcoholic fatty liver disease. Liver Int. 26, 151–156 (2006).
  Article PubMed Google Scholar
• Shimada, M. et al. Usefulness of a combined evaluation of the serum adiponectin level, HOMA-IR, and serum type IV collagen 7S level to predict the early stage of nonalcoholic steatohepatitis. Am. J. Gastroenterol. 102, 1931–1938 (2007).
  Article CAS PubMed Google Scholar
• Wieckowska, A. et al. In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease. Hepatology 44, 27–33 (2006).
  Article CAS PubMed Google Scholar
• Feldstein, A. E. et al. Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study. Hepatology 50, 1072–1078 (2009).
  Article CAS PubMed Google Scholar
• Alkhouri, N., Carter-Kent, C. & Feldstein, A. E. Apoptosis in nonalcoholic fatty liver disease: diagnostic and therapeutic implications. Expert Rev. Gastroenterol. Hepatol. 5, 201–212 (2011).
  Article PubMed PubMed Central Google Scholar
• Shen, J. et al. Non-invasive diagnosis of non-alcoholic steatohepatitis by combined serum biomarkers. J. Hepatol. 56, 1363–1370 (2012).
  Article CAS PubMed Google Scholar
• Sandrin, L. et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med. Biol. 29, 1705–1713 (2003).
  Article PubMed Google Scholar
• Roulot, D. et al. Liver stiffness values in apparently healthy subjects: Influence of gender and metabolic syndrome. J. Hepatol. 48, 606–613 (2008).
  Article PubMed Google Scholar
• Castera, L., Forns, X. & Alberti, A. Non-invasive evaluation of liver fibrosis using transient elastography. J. Hepatol. 48, 835–847 (2008).
  Article PubMed Google Scholar
• Castera, L. Noninvasive methods to assess liver disease in patients with hepatitis B or C. Gastroenterology 142, 1293–1302.e4 (2012).
  Article PubMed Google Scholar
• Yoneda, M. et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD). Dig. Liver Dis. 40, 371–378 (2008).
  Article CAS PubMed Google Scholar
• Nobili, V. et al. Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis. Hepatology 48, 442–448 (2008).
  Article CAS PubMed Google Scholar
• Wong, V. W. et al. Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology 51, 454–462 (2010).
  Article CAS PubMed Google Scholar
• Lupsor, M. et al. Performance of unidimensional transient elastography in staging non-alcoholic steatohepatitis. J. Gastrointestin. Liver Dis. 19, 53–60 (2010).
  PubMed Google Scholar
• Petta, S. et al. Reliability of liver stiffness measurement in non-alcoholic fatty liver disease: the effects of body mass index. Aliment. Pharmacol. Ther. 33, 1350–1360 (2011).
  Article CAS PubMed Google Scholar
• Gaia, S. et al. Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis. J. Hepatol. 54, 64–71 (2011).
  Article PubMed Google Scholar
• Myers, R. P. et al. Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients. Hepatology 55, 199–208 (2012).
  Article PubMed Google Scholar
• Wong, V. W. et al. Liver stiffness measurement using XL probe in patients with nonalcoholic fatty liver disease. Am. J. Gastroenterol. 107, 1862–1871 (2012).
  Article PubMed Google Scholar
• Ransohoff, D. F. & Feinstein, A. R. Problems of spectrum and bias in evaluating the efficacy of diagnostic tests. N. Engl. J. Med. 299, 926–930 (1978).
  Article CAS PubMed Google Scholar
• Poynard, T. et al. Standardization of ROC curve areas for diagnostic evaluation of liver fibrosis markers based on prevalences of fibrosis stages. Clin. Chem. 53, 1615–1622 (2007).
  Article CAS PubMed Google Scholar
• Castera, L. et al. Pitfalls of liver stiffness measurement: A 5-year prospective study of 13,369 examinations. Hepatology 51, 828–835 (2010).
  PubMed Google Scholar
• Wong, G. L. et al. Factors associated with unreliable liver stiffness measurement and its failure with transient elastography in the Chinese population. J. Gastroenterol. Hepatol. 26, 300–305 (2011).
  Article PubMed Google Scholar
• Friedrich-Rust, M. et al. Transient elastography with a new probe for obese patients for non-invasive staging of non-alcoholic steatohepatitis. Eur. Radiol. 20, 2390–2396 (2010).
  Article PubMed Google Scholar
• de Ledinghen, V. et al. Feasibility of liver transient elastography with FibroScan using a new probe for obese patients. Liver Int. 30, 1043–1048 (2010).
  Article CAS PubMed Google Scholar
• de Ledinghen, V. et al. Diagnosis of liver fibrosis and cirrhosis using liver stiffness measurement: comparison between M and XL probe of FibroScan®. J. Hepatol. 56, 833–839 (2012).
  Article PubMed Google Scholar
• Coco, B. et al. Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases. J. Viral Hepat. 14, 360–369 (2007).
  Article CAS PubMed Google Scholar
• Sagir, A., Erhardt, A., Schmitt, M. & Haussinger, D. Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage. Hepatology 47, 592–595 (2007).
  Article CAS Google Scholar
• Arena, U. et al. Acute viral hepatitis increases liver stiffness values measured by transient elastography. Hepatology 47, 380–384 (2008).
  Article CAS PubMed Google Scholar
• Millonig, G. et al. Extrahepatic cholestasis increases liver stiffness (FibroScan) irrespective of fibrosis. Hepatology 48, 1718–1723 (2008).
  Article PubMed Google Scholar
• Millonig, G. et al. Liver stiffness is directly influenced by central venous pressure. J. Hepatol. 52, 206–210 (2010).
  Article PubMed Google Scholar
• Mederacke, I. et al. Food intake increases liver stiffness in patients with chronic or resolved hepatitis C virus infection. Liver Int. 29, 1500–1506 (2009).
  Article PubMed Google Scholar
• Arena, U. et al. Liver stiffness is influenced by a standardized meal in patients with chronic HCV hepatitis at different stages of fibrotic evolution. Hepatology 58, 65–72 (2013).
  Article CAS PubMed Google Scholar
• Berzigotti, A. et al. Effect of meal ingestion on liver stiffness in patients with cirrhosis and portal hypertension. PLoS ONE 8, e58742 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Berzigotti, A. & Castera, L. Update on Ultrasound Imaging of Liver Fibrosis. J. Hepatol. 58, 180–182 (2013).
  Article Google Scholar
• Nightingale, K., Soo, M. S., Nightingale, R. & Trahey, G. Acoustic radiation force impulse imaging: in vivo demonstration of clinical feasibility. Ultrasound Med. Biol. 28, 227–235 (2002).
  Article PubMed Google Scholar
• Palmeri, M. L. et al. Noninvasive evaluation of hepatic fibrosis using acoustic radiation force-based shear stiffness in patients with nonalcoholic fatty liver disease. J. Hepatol. 55, 666–672 (2011).
  Article PubMed PubMed Central Google Scholar
• Yoneda, M. et al. Nonalcoholic fatty liver disease: US-based acoustic radiation force impulse elastography. Radiology 256, 640–647 (2010).
  Article PubMed Google Scholar
• Ochi, H. et al. Real-time tissue elastography for evaluation of hepatic fibrosis and portal hypertension in nonalcoholic fatty liver diseases. Hepatology 56, 1271–1278 (2012).
  Article PubMed Google Scholar
• Muthupillai, R. et al. Magnetic resonance elastography by direct visualization of propagating acoustic strain waves. Science 269, 1854–1857 (1995).
  Article CAS PubMed Google Scholar
• Talwalkar, J. A. et al. Magnetic resonance imaging of hepatic fibrosis: emerging clinical applications. Hepatology 47, 332–342 (2008).
  Article PubMed Google Scholar
• Kim, D., Kim, W. R., Talwalkar, J. A., Kim, H. J. & Ehman, R. L. Advanced fibrosis in nonalcoholic fatty liver disease: noninvasive assessment with MR elastography. Radiology 268, 411–419 (2013).
  Article PubMed PubMed Central Google Scholar
• Huwart, L. et al. Magnetic resonance elastography for the noninvasive staging of liver fibrosis. Gastroenterology 135, 32–40 (2008).
  Article PubMed Google Scholar
• Schuppan, D. & Afdhal, N. H. Liver cirrhosis. Lancet 371, 838–851 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Sheth, S. G., Flamm, S. L., Gordon, F. D. & Chopra, S. AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection. Am. J. Gastroenterol. 93, 44–48 (1998).
  Article CAS PubMed Google Scholar
• Angulo, P., Keach, J. C., Batts, K. P. & Lindor, K. D. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 30, 1356–1362 (1999).
  Article CAS PubMed Google Scholar
• Kruger, F. C. et al. APRI: a simple bedside marker for advanced fibrosis that can avoid liver biopsy in patients with NAFLD/NASH. S. Afr. Med. J. 101, 477–480 (2011).
  CAS PubMed Google Scholar
• Chitturi, S. et al. HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity. Hepatology 36, 142–149 (2002).
  Article CAS PubMed Google Scholar
• Bugianesi, E. et al. Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver. Hepatology 39, 179–187 (2004).
  Article CAS PubMed Google Scholar
• Manousou, P. et al. Serum ferritin is a discriminant marker for both fibrosis and inflammation in histologically proven non-alcoholic fatty liver disease patients. Liver Int. 31, 730–739 (2011).
  Article CAS PubMed Google Scholar
• Angulo, P. et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology 45, 846–854 (2007).
  Article CAS PubMed Google Scholar
• Dixon, J. B., Bhathal, P. S. & O'Brien, P. E. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 121, 91–100 (2001).
  Article CAS PubMed Google Scholar
• Harrison, S. A., Oliver, D., Arnold, H. L., Gogia, S. & Neuschwander-Tetri, B. A. Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease. Gut 57, 1441–1447 (2008).
  Article CAS PubMed Google Scholar
• Marceau, P. et al. Liver pathology and the metabolic syndrome X in severe obesity. J. Clin. Endocrinol. Metab. 84, 1513–1517 (1999).
  Article CAS PubMed Google Scholar
• Miyaaki, H. et al. Clinicopathological study of nonalcoholic fatty liver disease in Japan: the risk factors for fibrosis. Liver Int. 28, 519–524 (2008).
  Article PubMed Google Scholar
• Ratziu, V. et al. Liver fibrosis in overweight patients. Gastroenterology 118, 1117–1123 (2000).
  Article CAS PubMed Google Scholar
• Adams, L. A. et al. Complex non-invasive fibrosis models are more accurate than simple models in non-alcoholic fatty liver disease. J. Gastroenterol. Hepatol. 26, 1536–1543 (2011).
  Article CAS PubMed Google Scholar
• Cales, P. et al. Comparison of blood tests for liver fibrosis specfic or not specific to NAFLD. J. Hepatol. 50, 165–173 (2009).
  Article PubMed Google Scholar
• Shah, A. G. et al. Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. Clin. Gastroenterol. Hepatol. 7, 1104–1112 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Adams, L. A. et al. Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection. Clin. Chem. 51, 1867–1873 (2005).
  Article CAS PubMed Google Scholar
• Qureshi, K., Clements, R. H. & Abrams, G. A. The utility of the “NAFLD fibrosis score” in morbidly obese subjects with NAFLD. Obes. Surg. 18, 264–270 (2008).
  Article PubMed Google Scholar
• Wong, V. W. et al. Validation of the NAFLD fibrosis score in a Chinese population with low prevalence of advanced fibrosis. Am. J. Gastroenterol. 103, 1682–1688 (2008).
  Article PubMed Google Scholar
• Chalasani, N. et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology 142, 1592–1609 (2012).
  Article PubMed Google Scholar
• Guha, I. N. et al. Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers. Hepatology 47, 455–460 (2008).
  Article PubMed Google Scholar
• Kaneda, H., Hashimoto, E., Yatsuji, S. & Tokushige, K., Shiratori, K. Hyaluronic acid levels can predict severe fibrosis and platelet counts can predict cirrhosis in patients with nonalcoholic fatty liver disease. J. Gastroenterol. Hepatol. 21, 1459–1465 (2006).
  CAS PubMed Google Scholar
• Nobili, V. et al. Performance of ELF serum markers in predicting fibrosis stage in pediatric non-alcoholic fatty liver disease. Gastroenterology 136, 160–167 (2009).
  Article CAS PubMed Google Scholar
• Ratziu, V. et al. Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease. BMC Gastroenterol. 6, 6 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Sakugawa, H. et al. Clinical usefulness of biochemical markers of liver fibrosis in patients with nonalcoholic fatty liver disease. World J. Gastroenterol. 11, 255–259 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Santos, V. N. et al. Serum laminin, type IV collagen and hyaluronan as fibrosis markers in non-alcoholic fatty liver disease. Braz. J. Med. Biol. Res. 38, 747–753 (2005).
  Article PubMed Google Scholar
• Suzuki, A. et al. Hyaluronic acid, an accurate serum marker for severe hepatic fibrosis in patients with non-alcoholic fatty liver disease. Liver Int. 25, 779–786 (2005).
  Article CAS PubMed Google Scholar
• Johansen, J. S. et al. Serum YKL-40 is increased in patients with hepatic fibrosis. J. Hepatol. 32, 911–920 (2000).
  Article CAS PubMed Google Scholar
• Malik, R. et al. The clinical utility of biomarkers and the nonalcoholic steatohepatitis CRN liver biopsy scoring system in patients with nonalcoholic fatty liver disease. J. Gastroenterol. Hepatol. 24, 564–568 (2009).
  Article CAS PubMed Google Scholar
• Rosenberg, W. M. et al. Serum markers detect the presence of liver fibrosis: A cohort study. Gastroenterology 127, 1704–1713 (2004).
  Article PubMed Google Scholar
• Adams, L. Transient elastography in nonalcoholic fatty liver disease: making sense of echoes. Hepatology 51, 370–372 (2010).
  Article PubMed Google Scholar
• Castera, L. et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 128, 343–350 (2005).
  Article PubMed Google Scholar
• Poynard, T. et al. Concordance in a world without a gold standard: a new non-invasive methodology for improving accuracy of fibrosis markers. PLoS ONE 3, e3857 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Ngo, Y. et al. A prospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis C. Clin. Chem. 52, 1887–1896 (2006).
  CAS PubMed Google Scholar
• Naveau, S. et al. Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease. Hepatology 49, 97–105 (2009).
  Article PubMed Google Scholar
• Parkes, J. et al. Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease. Gut 59, 1245–1251 (2010).
  Article CAS PubMed Google Scholar
• Nunes, D. et al. Noninvasive markers of liver fibrosis are highly predictive of liver-related death in a cohort of HCV-infected individuals with and without HIV infection. Am. J. Gastroenterol. 105, 1346–1353 (2010).
  Article PubMed Google Scholar
• Vergniol, J. et al. Noninvasive tests for fibrosis and liver stiffness predict 5-year outcomes of patients with chronic hepatitis C. Gastroenterology 140, 1970–1979 (2011).
  Article PubMed Google Scholar
• Robic, M. A. et al. Liver stiffness accurately predicts portal hypertension related complications in patients with chronic liver disease: A prospective study. J. Hepatol. 55, 1017–1024 (2011).
  Article PubMed Google Scholar
• Kim, D., Kim, W. R., Kim, H. J. & Therneau, T. M. Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States. Hepatology 57, 1357–1365 (2013).
  Article CAS PubMed Google Scholar
• Treeprasertsuk, S., Bjornsson, E., Enders, F., Suwanwalaikorn, S. & Lindor, K. D. NAFLD fibrosis score: a prognostic predictor for mortality and liver complications among NAFLD patients. World J. Gastroenterol. 19, 1219–1229 (2013).
  Article PubMed PubMed Central Google Scholar
• Castera, L. & Pinzani, M. Biopsy and non-invasive methods for the diagnosis of liver fibrosis: does it take two to tango? Gut 59, 861–866 (2010).
  Article PubMed Google Scholar